Mainolfi Nello
Kymera Therapeutics, Inc. · Chief Executive Officer
Mainolfi Nello is listed in filings as Chief Executive Officer at Kymera Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 29, 2026, including sale activity. Recent filings connect the profile to Kymera Therapeutics, Inc. (KYMR). The current snapshot covers public activity from Jan 13, 2025 to Apr 29, 2026. Reported amounts are shown as $1.4M to $77.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1M17k shares | SellApr 29, 2026 | $80.74 | $113.99 | |
| $985k12.1k shares | SellApr 29, 2026 | $81.70 | $113.99 | |
| $77k936 shares | SellApr 29, 2026 | $82.45 | $113.99 |